Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.
2.
3.

Late gadolinium uptake demonstrated with magnetic resonance in patients where automated PERFIT analysis of myocardial SPECT suggests irreversible perfusion defect.

Rosendahl L, Blomstrand P, Ohlsson JL, Björklund PG, Ahlander BM, Starck SA, Engvall JE.

BMC Med Imaging. 2008 Dec 12;8:17. doi: 10.1186/1471-2342-8-17.

4.

Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".

Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV; Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.

PMID:
18344033
5.

Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.

Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY.

Circulation. 2006 Jul 4;114(1):32-9. Epub 2006 Jun 26.

6.

Head-to-head comparison between delayed enhancement and percent infarct mapping for assessment of myocardial infarct size in a canine model.

Ruzsics B, Surányi P, Kiss P, Brott BC, Elgavish A, Simor T, Elgavish GA.

J Magn Reson Imaging. 2008 Dec;28(6):1386-92. doi: 10.1002/jmri.21571.

PMID:
19025946
7.

Multidetector computed tomography in reperfused acute myocardial infarction. Assessment of infarct size and no-reflow in comparison with cardiac magnetic resonance imaging.

Jacquier A, Boussel L, Amabile N, Bartoli JM, Douek P, Moulin G, Paganelli F, Saeed M, Revel D, Croisille P.

Invest Radiol. 2008 Nov;43(11):773-81. doi: 10.1097/RLI.0b013e318181c8dd.

PMID:
18923256
8.

Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction.

Choi CJ, Haji-Momenian S, Dimaria JM, Epstein FH, Bove CM, Rogers WJ, Kramer CM.

J Cardiovasc Magn Reson. 2004;6(4):917-25.

PMID:
15646895
9.

Comparison of infarct size changes with delayed contrast-enhanced magnetic resonance imaging and electrocardiogram QRS scoring during the 6 months after acutely reperfused myocardial infarction.

Bang LE, Ripa RS, Grande P, Kastrup J, Clemmensen PM, Wagner GS.

J Electrocardiol. 2008 Nov-Dec;41(6):609-13. doi: 10.1016/j.jelectrocard.2008.06.011. Epub 2008 Sep 14.

PMID:
18790502
10.
11.

Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model.

Amado LC, Gerber BL, Gupta SN, Rettmann DW, Szarf G, Schock R, Nasir K, Kraitchman DL, Lima JA.

J Am Coll Cardiol. 2004 Dec 21;44(12):2383-9.

12.

Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.

Yan AT, Gibson CM, Larose E, Anavekar NS, Tsang S, Solomon SD, Reynolds G, Kwong RY.

J Cardiovasc Magn Reson. 2006;8(6):831-7.

PMID:
17060106
13.

[Quantification of microvascular obstruction in acute myocardial infarction using cardiac MRI].

Nassenstein K, Waltering K, Hollenhorst M, Bruder O, Schlosser T, Hunold P, Barkhausen J.

Rofo. 2009 Jul;181(7):669-74. doi: 10.1055/s-0028-1109203. Epub 2009 Apr 7. German.

PMID:
19353485
14.

Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging.

Setser RM, Bexell DG, O'Donnell TP, Stillman AE, Lieber ML, Schoenhagen P, White RD.

J Magn Reson Imaging. 2003 Oct;18(4):434-41.

PMID:
14508780
15.

Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.

Bauner KU, Reiser MF, Huber AM.

Invest Radiol. 2009 Feb;44(2):95-104. doi: 10.1097/RLI.0b013e3181911eab.

PMID:
19077911
16.

Importance of standardized assessment of late gadolinium enhancement for quantification of infarct size by cardiac magnetic resonance: implications for comparison with electrocardiogram.

Welinder A, Hakacova N, Martin T, Engblom H.

J Electrocardiol. 2011 Sep-Oct;44(5):538-43. doi: 10.1016/j.jelectrocard.2011.06.007.

PMID:
21872000
17.

Quantitative clinical assessment of chronic anterior myocardial infarction with delayed enhancement magnetic resonance imaging and QRS scoring.

Engblom H, Wagner GS, Setser RM, Selvester RH, Billgren T, Kasper JM, Maynard C, Pahlm O, Arheden H, White RD.

Am Heart J. 2003 Aug;146(2):359-66.

PMID:
12891208
18.

Fully automated registration and warping of contrast-enhanced first-pass perfusion images.

Gallippi CM, Kramer CM, Hu YL, Vido DA, Reichek N, Rogers WJ.

J Cardiovasc Magn Reson. 2002;4(4):459-69.

PMID:
12549233
19.

Three-dimensional magnetic resonance imaging technique for myocardial-delayed hyperenhancement: a comparison with the two-dimensional technique.

Tatli S, Zou KH, Fruitman M, Reynolds HG, Foo T, Kwong R, Yucel EK.

J Magn Reson Imaging. 2004 Sep;20(3):378-82.

PMID:
15332243
20.

Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR.

Bondarenko O, Beek AM, Hofman MB, Kühl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC.

J Cardiovasc Magn Reson. 2005;7(2):481-5.

PMID:
15881532

Supplemental Content

Support Center